Laidlaw analyst Yale Jen lowered the price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Ionis Pharmaceuticals (IONS) PT Lowered to $55 at BofA SecuritiesOctober 18, 2021 6:25 AM Ionis Pharmaceuticals (IONS) and Biogen (BIIB) Report Updates on tofersen Phase 3 VALOR study in SOD1-ALSOctober 18, 2021 5:27 AM Ionis' partner Biogen provides update on tofersen Phase 3 VALOR study in SOD1-ALSOctober 17, 2021 4:20 PM Topline Results from Tofersen Phase 3 Study and its Open Label Extension in SOD1-ALS to be Presented at the American Neurological Association Annual MeetingOctober 14, 2021 4:06 PM Topline Results from Tofersen Phase 3 Study and its Open Label Extension in SOD1-ALS to be Presented at the American Neurological Association Annual MeetingOctober 14, 2021 4:06 PM